TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes

Neuropsychopharmacology

Volumn 34, Issue 6, 2009, Pages 1601-1608

  Sun, Yuhua ^a   Zupan, Bojana ^b   Raaka, Bruce M ^a   Toth, Miklos ^b   Gershengorn, Marvin C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anxiety; Behavioral changes; Depression; Thyrotropin releasing hormone; Thyrotropin releasing hormone receptors; TRHR2 deficient mouse

Indexed keywords

GLUCOSE; PROLACTIN; PROTIRELIN RECEPTOR; THYROTROPIN; THYROXINE;

AFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD CHEMISTRY; BLOOD EXAMINATION; BLOOD SAMPLING; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIMMING TEST; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOLOGY; HYPOPHAGIA; HYPOTHYROIDISM; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MALE; MAZE TEST; MOOD; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSGENIC MOUSE;

ANIMALS; ANXIETY; BLOOD GLUCOSE; DEPRESSION; DIET; DIETARY FATS; FEMALE; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; PROLACTIN; RECEPTORS, THYROTROPIN-RELEASING HORMONE; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE;

EID: 64949145980     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.217     Document Type: Article

References (45)

1. Alkemade A, Unmehopa UA, Brouwer JP, Hoogendijk WJ, Wiersinga WM, Swaab DF et al (2003). Decreased thyrotropin-releasing hormone gene expression in the hypothalamic para-ventricular nucleus of patients with major depression. Mol Psychiatry 8: 838-839.
2. Bartalena L, Placidi GF, Martino E, Falcone M, Pellegrini L, Dell'Osso L et al (1990). Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives. J Clin Endocrinol Metab 71: 650-655.
3. Bissiere S, Plachta N, Hoyer D, McAllister KH, Olpe HR, Grace AA et al (2008). The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol Psychiatry 63: 821-831.
4. Cao J, O'Donnell D, Vu H, Payza K, Pou C, Godbout C et al (1998). Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. J Biol Chem 273: 32281-32287.
5. Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238-245.
6. de la Pena P, Delgado LM, del Camino D, Barros F (1992). Two isoforms of the thyrotropin-releasing hormone receptor generated by alternative splicing have indistinguishable functional properties. J Biol Chem 267: 25703-25708.
7. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996). Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911-921.
8. Dulawa SC, Hen R (2005). Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29: 771-783.
9. Dulawa SC, Holick KA, Gundersen B, Hen R (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29: 1321-1330.
10. Duncan GE, Knapp DJ, Johnson KB, Breese GR (1996). Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. J Pharmacol Exp Ther 277: 1076-1089.
11. Duthie SM, Taylor PL, Anderson L, Cook J, Eidne KA (1993). Cloning and functional characterisation of the human TRH receptor. Mol Cell Endocrinol 95: R11-R15.
12. Gary KA, Sevarino KA, Yarbrough GG, Prange Jr AJ, Winokur A (2003). The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 305: 410-416.
13. Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I et al (2007). cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. J Neurosci 27: 7860-7868.
14. Gutierrez-Mariscal M, de Gortari P, Lopez-Rubalcava C, Martinez A, Joseph-Bravo P (2008). Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety. Psychoneuroendocrinology 33: 198-213.
15. Harder S, Dammann O, Buck F, Zwiers H, Lederis K, Richter D et al (2001a). Cloning of two thyrotropin-releasing hormone receptor subtypes from a lower vertebrate (Catostomus com-mersoni): functional expression, gene structure, and evolution. Gen Comp Endocrinol 124: 236-245.
16. Harder S, Lu X, Wang W, Buck F, Gershengorn MC, Bruhn TO (2001b). Regulator of G protein signaling 4 suppresses basal and thyrotropin releasing-hormone (TRH)-stimulated signaling by two mouse TRH receptors, TRH-R(1) and TRH-R(2). Endocrinology 142: 1188-1194.
17. Itadani H, Nakamura T, Itoh J, Iwaasa H, Kanatani A, Borkowski J et al (1998). Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors. Biochem Biophys Res Commun 250: 68-71.
18. Khan AA, Gardner CO, Prescott CA, Kendler KS (2002). Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry 159: 1427-1429.
19. Kulkarni RN, Wang ZL, Akinsanya KO, Bennet WM, Wang RM, Smith DM et al (1995). Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Endocrinology 136: 5155-5164.
20. Luo LG, Yano N (2004). Expression of thyrotropin-releasing hormone receptor in immortalized beta-cell lines and rat pancreas. J Endocrinol 181: 401-412.
21. Matre V, Karlsen HE, Wright MS, Lundell I, Fjeldheim AK, Gabrielsen OS et al (1993). Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Bio-phys Res Commun 195: 179-185.
22. Merali Z, Levac C, Anisman H (2003). Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54: 552-565.
23. Mulla CM, Geras-Raaka E, Raaka BM, Gershengorn MC (2008). High levels of TRH receptors activate programmed cell death in human pancreatic precursors. Pancreas 2009 (in press).
24. O'Dowd BF, Lee DK, Huang W, Nguyen T, Cheng R, Liu Y et al (2000). TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol Endocrinol 14: 183-193.
25. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147: 162-167.
26. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 95: 10734-10739.
27. Pekary AE, Faull KF, Paulson M, Lloyd RL, Sattin A (2005). TRH-like antidepressant peptide, pyroglutamyltyroslyprolineamide, occurs in rat brain. J Mass Spectrom 40: 1232-1236.
28. Pekary AE, Stevens SA, Sattin A (2006). Circadian rhythms of TRH-like peptide levels in rat brain. Brain Res 1125: 67-76.
29. Porsolt RD, Bertin A, Jalfre M (1978). 'Behavioural despair' in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51: 291-294.
30. Rabeler R, Mittag J, Geffers L, Ruther U, Leitges M, Parlow AF et al (2004). Generation of thyrotropin-releasing hormone receptor 1-deficient mice as an animal model of central hypothyroidism. Mol Endocrinol 18: 1450-1460.
31. Sattin A (1999). The role of TRH and related peptides in the mechanism of action of ECT. J Ect 15: 76-92.
32. Sattin A, Pekary AE, Blood J (2008). Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues. Neuroendocrinology 88: 135-146.
33. Sellar RE, Taylor PL, Lamb RF, Zabavnik J, Anderson L, Eidne KA (1993). Functional expression and molecular characterization of the thyrotrophin- releasing hormone receptor from the rat anterior pituitary gland. J Mol Endocrinol 10: 199-206.
34. Sibille E, Pavlides C, Benke D, Toth M (2000). Genetic inactivation of the serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20: 2758-2765.
35. Steckler T, Holsboer F (1999). Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46: 1480-1508.
36. Straub RE, Frech GC, Joho RH, Gershengorn MC (1990). Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc Natl Acad Sci USA 87: 9514-9518.
37. Sun Y, Lu X, Gershengorn MC (2003). Thyrotropin-releasing hormone receptors - similarities and differences. J Mol Endocrinol 30: 87-97.
38. Sun YM, Millar RP, Ho H, Gershengorn MC, Illing N (1998). Cloning and characterization of the chicken thyrotropin-releasing hormone receptor. Endocrinology 139: 3390-3398.
39. Takata M, Shimada Y, Ikeda A, Sekikawa K (1998). Molecular cloning of bovine thyrotropin-releasing hormone receptor gene. J Vet Med Sci 60: 123-127.
40. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T et al (1997). Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94: 10862-10867.
41. Yamada M, Shibusawa N, Hashida T, Ozawa A, Monden T, Satoh T et al (2000). Expression of thyrotropin-releasing hormone (TRH) receptor subtype 1 in mouse pancreatic islets and HIT-T15, an insulin-secreting clonal beta cell line. Life Sci 66: 1119-1125.
42. Yang X, Li C, Xu X, Deng C (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA 95: 3667-3672.
43. Yarbrough GG, Kamath J, Winokur A, Prange Jr AJ (2007). Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses 69: 1249-1256.
44. Zeng H, Schimpf BA, Rohde AD, Pavlova MN, Gragerov A, Bergmann JE (2007). Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol 21: 2795-2804.
45. Zhao D, Yang J, Jones KE, Gerald C, Suzuki Y, Hogan PG et al (1992). Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. Endocrinology 130: 3529-3536.